A novel unit created to care for critically ill patients significantly sped access to specialized care.
A novel unit created to care for critically ill patients at the University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) significantly sped access to specialized care, a new study published online February 23, 2016, in the Journal of the American College of Surgeons reports. The unit, the nation’s first Critical Care Resuscitation Unit (CCSU), is a 6-bed, short-stay intensive care unit (ICU) located within the Shock Trauma Critical Care Tower at UMMC. It is staffed 24/7 by physicians and nurses with broad and diverse critical care experience.
Thomas M. Scalea, MD, and colleagues said CCSU at UMMC was designed as a unit midway between an emergency department (ED) and ICU similar to their Trauma Resuscitation Unit but for non-trauma patients. This design was meant to address the fact that while organized trauma systems are in place for transferring patients from the scene of an accident to a specialized trauma center, no formal systems have been in place for transferring non-trauma patients in need of often life-saving care. Patient access to specialty care in the academic medical center setting is largely dependent on the availability of ICU beds in the receiving hospital. Without an open bed to receive the patient, wait times for transfers to academic medical centers with highly specialized facilities can mean the difference between life and death.
During the first full year of operation of the new unit, for the subset of adult patients admitted for critical care, transfers increased 64.5% compared with a previous year and patients arrived in nearly half the time (129 minutes vs 234 minutes).
“It has been phenomenally successful in its intended mission to serve critically ill patients, and we believe it should serve as a model for other institutions,” said Dr Scalea.
He noted that prior to the new unit being built, despite UMMC’s operation of an interhospital call center for the transfer of critically ill patients, patients needing immediate critical care were sometimes unable to be transferred if a specialized ICU bed was not available, or transfer times were longer than desired.
In addition to decreasing time to arrival and increasing transfers, the CCRU also significantly decreased the percentage of lost admissions from 25.7% to 14% in this subset of transfer patients requiring critical care.
The team said that they admitted nearly 1000 additional transfer patients in the first year alone since opening the CCRU, so that adding 6 beds and borrowing practices honed in the Shock Trauma Unit made their entire system more efficient. More research will be done to follow up on this initial report.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More